
Kelly K Curtis MD
Assistant Professor, Internal Medicine, Mayo Medical School
Join to view full profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Dr. Curtis is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
Albany Medical CollegeClass of 2004
Certifications & Licensure
AZ State Medical License 2005 - 2028
MN State Medical License 2005 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014-2016
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2014-2016
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014-2016
Clinical Trials
- Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer Start of enrollment: 2013 Jan 10
- Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Publications & Presentations
PubMed
- 25 citationsMulticenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies.Alexander I. Spira, Aaron R. Hansen, Wael A. Harb, Kelly K. Curtis, Erina Koga-Yamakawa
Targeted Oncology. 2021-05-03 - 10 citationsMolecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholang...Jan B. Egan, David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos
JCO Precision Oncology. 2017-08-01 - 8 citationsMucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer.Mauricio E. Gamez, Michele Y. Halyard, Michael L. Hinni, Richard E. Hayden, Thomas H. Nagel
The Annals of Otology, Rhinology, and Laryngology. 2017-01-05
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: